Holen Sie sich die Stockscreener-App
1.69
1.74%
-0.03
Handel nachbörslich:
1.67
-0.02
-1.18%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LXRX?
Forum
Prognose
Aktiensplit
Finanzdaten der Lexicon Pharmaceuticals Inc-Aktie (LXRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
61.27%
5.493
|
14.18 | 28.87 | 1.262 | 26.55 |
| Cost Of Revenue |
1,910%
0.201
|
0.01 | 0.033 | 0.03 | 0.348 |
| Gross Profit |
62.66%
5.292
|
14.17 | 28.83 | 1.232 | 26.21 |
Operating Expenses
|
23.85%
20.07
|
26.36 | 25.10 | 26.91 | 58.94 |
| Benefits Costs and Expenses |
23.12%
20.27
|
26.37 | 25.13 | 26.94 | 59.29 |
| Costs And Expenses |
23.12%
20.27
|
26.37 | 25.13 | 26.94 | 59.29 |
| Operating Income/Loss |
21.28%
-14.78
|
-12.19 | 3.736 | -25.68 | -32.74 |
| Income/Loss From Continuing Operations Before Tax |
21.28%
-14.78
|
-12.19 | 3.252 | -25.30 | -32.74 |
| Income/Loss From Continuing Operations After Tax |
21.62%
-15.53
|
-12.77 | 3.252 | -25.30 | -33.77 |
|
Net Income/Loss
|
21.62%
-15.53
|
-12.77 | 3.252 | -25.30 | -33.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.97%
0.126
|
363.40 | 363.29 | 362.07 | 13.92 |
| Diluted Average Shares |
99.97%
0.126
|
363.40 | 363.57 | 362.07 | 13.92 |
| Basic Earnings Per Share |
0.00%
-0.04
|
-0.04 | 0.01 | -0.07 | -0.09 |
| Diluted Earnings Per Share |
0.00%
-0.04
|
-0.04 | 0.01 | -0.07 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):